Telesis Bio, Inc. (TBIO) Financials
TBIO Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-09-30 | 105.0 million | 58.5 million |
2023-06-30 | 114.5 million | 86.6 million |
2023-03-31 | 89.2 million | 52.5 million |
2022-12-31 | 81.4 million | 34.8 million |
TBIO Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-09-30 | -6.0 million | 1.2 million |
2023-06-30 | -11.5 million | 1.0 million |
2023-03-31 | -11.6 million | 1.2 million |
2022-12-31 | -6.4 million | 1.2 million |
TBIO Net Income
No data available :(
TBIO Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-09-30 | 41.5 million | - | 29.5 million |
2023-06-30 | 47.5 million | 19.9 million | 29.4 million |
2023-03-31 | 32.2 million | - | 22.0 million |
2022-12-31 | 43.8 million | - | 1.8 million |
TBIO Shares Outstanding
TBIO Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-09-30 | 104000 | 4.1 million | 6.3 million | 2.7 million |
2023-06-30 | 1.2 million | 4.6 million | 5.7 million | 3.4 million |
2023-03-31 | 470000 | 5.1 million | 5.6 million | 3.8 million |
2022-12-31 | 763000 | 4.1 million | 5.5 million | 4.7 million |
TBIO Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-09-30 | 5.6 million | 2.6 million |
2023-06-30 | 8.7 million | 3.0 million |
2023-03-31 | 6.3 million | 2.8 million |
2022-12-31 | 9.5 million | 3.0 million |
TBIO
Price: $0.34
52 week price:
Earnings Per Share: -1.64 USD
P/E Ratio: -0.25
Exchange: NMS
Sector: Healthcare
Industry: Medical Devices
Volume: 19200
Market Capitalization: 9.9 million